Yalonda Howze, See Remarks at Codiak BioSciences, Inc. (CDAK), sold 3,115 shares at $2.21 ($4K) on 2022-08-17, disclosed to the SEC on 2023-02-21.
Open-market sale of $4k CDAK by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.21 | 1,512 | $3K | 77.9% |
| 2 | $0.59 | 1,603 | $946 | 22.1% |
| Total | $1.38 avg | 3,115 | $4K | 100% |
| Filing → |